Immatics N.V. Ordinary Shares (IMTX)
Immatics N.V. Ordinary Shares
XNAS:IMTX
10.18
$11.00 - 125.00
$8.21 - 150.00
$9.91
$10.96
$10.89
$11.87
12.41
3.3
1648054
684180.4
95954730.3
Chart
TendieTensor AI Analysis
Company
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Fundamentals
423
-9.310000
2.947240
-0.42
100
121.55M
121.56M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own IMTX. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.